DHL to Acquire SDS Rx, Expand Healthcare Capabilities
By Billy Gray
DHL said it agreed to acquire SDS Rx, a U.S. healthcare-transportation specialist backed by HCI Equity Partners, for an undisclosed sum.
The German logistics company--formally called Deutsche Post--said Tuesday that the deal would bolster the life sciences and healthcare capabilities of its DHL Supply Chain arm. By acquiring SDS Rx, which focuses on last-mile delivery, DHL will be present in every stage of the life sciences and healthcare supply chain, a field where it sees significant opportunities, it said.
Specialty pharmacies handling especially complex and expensive medicines for serious or rare diseases already account for 50% of U.S. prescription drug spending, and the number of patients they serve grew 12% between 2018 and 2022, DHL said.
This will be DHL's second healthcare acquisition in 2025. Earlier this year, it acquired CryoPDP, a specialty courier focused on clinical trials, biopharmaceuticals and cell and gene therapies.
Write to Billy Gray at william.gray@wsj.com
(END) Dow Jones Newswires
September 09, 2025 09:14 ET (13:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States